Journal: iScience
Article Title: Targeted delivery of immune-stimulating bispecific RNA, inducing apoptosis and anti-tumor immunity in cancer cells
doi: 10.1016/j.isci.2024.109068
Figure Lengend Snippet: Simultaneous activation of RIG-I and silencing of PLK1 mediated by mAb-siPLK1-5′ppp 1 on A549-Dual siPLK1-5′ppp was delivered by either RNAiMAX or EphA2-antibody. (A) RIG-I-dependent activation of the IRF pathway (N = 6, triplicates). (B) RIG-I-dependent activation of the NF-κB pathway (N = 6, triplicates). Dual activity of the siPLK1-5′ppp delivered by either RNAiMAX or EphA2-antibody regarding RIG-I/PLK1 expression levels or cell-cycle arrest. (C) Western-blot on RIG-I, PLK1, and GAPDH, showing a simultaneous PLK1 knockdown and RIG-I activation, 72 h after incubation at 40 nM. (D) Proportion of cells in G2/M phase analyzed by FACS after 24 h of incubation at 40 nM (N = 2, triplicates). Data are presented as mean ± SD. Significancy was assessed by comparing treated cells with non-treated cells, ns = non-significant, ∗∗∗ = p < 0.0005, ∗∗∗∗ = p < 0.00005).
Article Snippet: A549-Dual RIG-I KO , InvivoGen , a549d-korigi.
Techniques: Activation Assay, Activity Assay, Expressing, Western Blot, Knockdown, Incubation